Supplement Bioavailability: The Complete Science of Absorption, Forms, and Co-Factors

Supplement Bioavailability: The Complete Science of Absorption, Forms, and Co-Factors

You could be taking a supplement with 500 mg printed on the label and absorbing fewer than 50 mg of active compound into your bloodstream. That gap — between the label dose and what actually reaches your tissues — is what scientists call bioavailability, and it's arguably the most underappreciated concept in the entire supplement industry.

Bioavailability is formally defined as the fraction of an ingested dose that enters systemic circulation in an unchanged, biologically active form. For intravenous drugs, bioavailability is 100% by definition. For oral supplements, it can range from under 5% (magnesium oxide, non-heme iron in some populations) to near 90% (certain liposomal and chelated forms). That's not a rounding error — that's the difference between a supplement that works and one that doesn't.

This pillar guide covers the complete science: the physiological barriers that govern absorption, the molecular chemistry behind different supplement forms, why co-factors matter as much as the ingredient itself, and how modern personalized platforms like Ones translate this science into formulas built around clinically validated ingredient forms.

---

Why Most Supplements Fail Before They Reach Your Cells

The gastrointestinal tract is not a passive tube. It is an active, highly selective barrier system designed to absorb nutrients while excluding pathogens, undigested proteins, and potentially harmful compounds. For supplement manufacturers, this selectivity creates a formidable set of obstacles.

The four primary absorption barriers are:

1. Gastric acid degradation — Stomach pH (1.5–3.5 in a fasted state) denatures proteins and breaks down certain compounds before they even reach the small intestine. This is why enteric-coated delivery systems were developed for acid-labile ingredients like pancreatic enzymes and some probiotic strains.

1. First-pass hepatic metabolism — Compounds absorbed in the small intestine enter the portal vein and are processed by the liver before reaching systemic circulation. The liver's cytochrome P450 enzyme system can substantially reduce the active concentration of certain fat-soluble vitamins and herbal extracts.

1. Transporter competition at the intestinal brush border — Minerals in particular share transport proteins. Calcium and magnesium compete for the same TRPM7 and TRPV6 channels; non-heme iron competes with zinc at the DMT1 transporter. Taking large doses of competing minerals together can significantly reduce absorption of both (Sandström 2001, Journal of Nutrition, doi:10.1093/jn/131.4.1378S).

1. Particle size and solubility — A compound must dissolve in gastrointestinal fluid before it can be absorbed. Hydrophobic (fat-soluble) compounds like CoQ10, curcumin, and vitamins D, E, and K have poor aqueous solubility and rely on dietary fat and bile emulsification to form absorbable micelles.

Understanding these barriers explains why the same nutrient can have dramatically different bioavailability depending on its molecular form, the delivery vehicle, what else is in the capsule, and what you ate before taking it.

---

Supplement Absorption Science: What Happens From Capsule to Cell

The journey of a supplement from capsule to cellular receptor involves several distinct physiological phases, each of which can be optimized or undermined by formulation choices.

Phase 1: Disintegration and Dissolution

A capsule or tablet must first disintegrate — physically break apart — and then dissolve into gastrointestinal fluid. Poorly manufactured tablets can pass through the gut intact. USP dissolution testing standards require that most oral dosage forms release ≥75% of their labeled content within 45 minutes under controlled conditions, but this standard applies primarily to pharmaceuticals and is not uniformly enforced in the supplement industry.

Gelatin and vegetable cellulose capsules generally disintegrate faster than compressed tablets. Liquid-filled softgels are faster still and provide a solubilized environment that accelerates dissolution of fat-soluble ingredients.

Phase 2: Absorption Across the Intestinal Epithelium

Once dissolved, a compound must cross the single-cell-thick epithelial lining of the small intestine. There are several pathways:

• Passive transcellular diffusion: Small, lipophilic molecules pass directly through cell membranes down a concentration gradient. Vitamins A, D, E, and K use this route.
• Active transport: Minerals and water-soluble vitamins use specific carrier proteins. Vitamin B12 requires intrinsic factor for ileal absorption; folate uses the reduced folate carrier (RFC-1).
• Endocytosis/transcytosis: Large molecules and some nanoparticle delivery systems (including liposomal formulations) can be engulfed by intestinal cells and transported across intact.
• Paracellular transport: Movement through tight junctions between cells, which is tightly regulated and typically restricted to small, water-soluble molecules.

Phase 3: Lymphatic vs. Portal Venous Delivery

Lipid-soluble nutrients packaged into chylomicrons (fat transport particles assembled in intestinal cells) bypass the portal vein entirely and enter the lymphatic system, emerging into systemic circulation via the thoracic duct. This is a critical advantage: it sidesteps first-pass hepatic metabolism. Fat-soluble vitamins, CoQ10, and omega-3 fatty acids all use this pathway, which is why taking them with a fat-containing meal meaningfully increases their bioavailability.

A 2019 randomized crossover trial in healthy adults found that CoQ10 absorption increased by approximately 50% when taken with a high-fat meal versus a fat-free meal (Bhagavan & Chopra, Mitochondrion 2006; PMID: 16524757 — foundational work confirmed in multiple subsequent trials). For vitamin D3 specifically, a study by Mulligan & Bhagwat (2010) demonstrated that taking D3 with the largest meal of the day, which typically contains the most fat, increased serum 25(OH)D levels by approximately 50% compared to taking it on an empty stomach (PMID: 20200983).

---

Best Form of Supplements: A Molecule-by-Molecule Breakdown

Form selection is the single most evidence-backed lever in supplement bioavailability. This is not opinion — there are controlled absorption studies directly comparing different chemical forms of the same nutrient.

Magnesium: Why Form Is Everything

Magnesium is the canonical example of how radically form affects bioavailability. At least a dozen distinct magnesium salts exist in the supplement market, with dramatically different absorption profiles:

A head-to-head study published in Magnesium Research found that magnesium citrate produced significantly greater increases in plasma magnesium than magnesium oxide over a 60-day period in healthy volunteers (Walker et al. 2003; PMID: 14596323). For sleep and neuromuscular applications, glycinate and threonate forms are preferred precisely because of their transport mechanisms. Ones includes a Magnesium Complex blend that combines multiple forms to capture both systemic and neurological benefits — a strategy supported by the differential tissue distribution data across magnesium salt studies.

Folate: The MTHFR Problem

Folic acid (the synthetic oxidized form found in most multivitamins) must be converted to 5-methyltetrahydrofolate (5-MTHF) by the MTHFR enzyme before the body can use it. Approximately 40–60% of the global population carries a polymorphism in the MTHFR gene that reduces this conversion efficiency by 35–70% (Wilcken et al. 2003; PMID: 12816104). For these individuals, folic acid supplementation may raise unmetabolized folic acid levels in plasma — a marker now associated with reduced natural killer cell cytotoxicity — while failing to raise active folate status.

The superior form is methylfolate (5-MTHF), which bypasses the MTHFR conversion step entirely. This is a clear case where the "best form" is not the cheapest or most common form — it's the one that accounts for human genetic variability.

Vitamin K: K1 vs. K2, and MK-4 vs. MK-7

Vitamin K1 (phylloquinone) is preferentially retained by the liver for clotting factor synthesis. Vitamin K2 (menaquinone) — particularly the long-chain MK-7 form — has a half-life of approximately 72 hours compared to K1's 1–2 hours, distributes to extrahepatic tissues including bone and vasculature, and more effectively activates osteocalcin and matrix Gla protein (MGP), the proteins responsible for directing calcium into bone rather than arterial walls (Schurgers et al. 2007; PMID: 17138823). MK-7 at 90–200 mcg daily is the form with the most robust clinical evidence for cardiometabolic and bone health outcomes, which is why quality platforms pair D3 specifically with MK-7 rather than K1. Vitamin D3 and K2 synergy is one of the most evidence-backed co-factor pairings in nutritional science.

Omega-3: Triglyceride vs. Ethyl Ester

Most high-concentrate omega-3 supplements on the market are in the re-esterified ethyl ester (EE) form — a result of the molecular distillation process used to concentrate EPA and DHA. Natural triglyceride (rTG) form omega-3s are absorbed approximately 70% better than EE forms, as demonstrated in a randomized crossover study that measured postprandial plasma EPA+DHA over 72 hours (Dyerberg et al. 2010; PMID: 20638827). Phospholipid-bound omega-3s (as found in krill oil) show even higher absorption per gram due to their direct compatibility with gut lymphatic transport. For optimal EPA/DHA dosing, form matters as much as the milligram count on the label.

---

Chelated Minerals Bioavailability: The Science of Amino Acid Bonding

Chelation is the process of bonding a mineral ion to an organic ligand — most commonly an amino acid — to protect it from competing ions, alkaline pH, and phytate interference in the gut. The term comes from the Greek chele (claw), describing how the organic molecule wraps around the mineral.

Why Chelation Works

Inorganic mineral salts (oxides, carbonates, sulfates) dissociate in stomach acid and release free ions that must compete for limited intestinal transporter capacity. Chelated minerals, by contrast, can be absorbed via peptide transport pathways (specifically PEPT1) that are separate from the mineral ion transporters — effectively giving them a second absorption route and reducing competitive interference.

The most studied amino acid chelates include:

• Magnesium bisglycinate — two glycine molecules per magnesium ion; high GI tolerability, studied at doses of 300–400 mg elemental magnesium
• Zinc bisglycinate — significantly higher absorption than zinc gluconate or zinc sulfate; a crossover trial showed 43% higher relative absorption compared to zinc oxide (Gandia et al. 2007; PMID: 17906191)
• Iron bisglycinate — the preferred form for GI-sensitive populations; equivalent efficacy to ferrous sulfate at lower doses with dramatically fewer GI side effects (Szarfarc et al. 2001, Nutrition Research)
• Chromium picolinate — picolinic acid chelation increases intestinal absorption; however, high-dose chromium picolinate has been associated with oxidative DNA damage in vitro, so dosing should remain at evidence-supported ranges (200–400 mcg/day)

Phytate: The Hidden Absorption Blocker

Phytic acid (inositol hexaphosphate) is the primary phosphorus storage molecule in plant seeds, grains, and legumes. It binds divalent minerals (zinc, iron, calcium, magnesium) in the gut, forming insoluble phytate complexes that pass through the intestine unabsorbed. For populations with high grain and legume intake — and particularly for vegetarians and vegans — phytate-mineral interaction can reduce zinc absorption by up to 40–50% and iron absorption by a comparable margin (Sandström 2001).

Chelated mineral forms show significantly greater resilience to phytate interference because the amino acid ligand competes successfully with phytate for the mineral binding site, preserving bioavailability even in a high-phytate dietary context. This makes chelated minerals especially important in formulas for individuals eating primarily plant-based diets.

---

Liposomal Supplement Absorption: Engineering Around Gut Barriers

Liposomal delivery represents one of the most significant advances in supplement bioavailability technology over the past two decades. A liposome is a spherical phospholipid bilayer vesicle — structurally identical to a cell membrane — that encapsulates a water-soluble or fat-soluble nutrient in its aqueous core or lipid bilayer, respectively.

The Mechanism

Because liposomes mimic cell membranes, they can fuse directly with intestinal epithelial cells via endocytosis, bypassing transporter competition and first-pass hepatic metabolism. The encapsulated ingredient is delivered intracellularly in essentially intact form, dramatically increasing the fraction that reaches systemic circulation.

Evidence in Key Nutrients

Liposomal Vitamin C: Standard ascorbic acid absorption is transporter-saturable — above approximately 1,000 mg/dose, absorption efficiency drops sharply due to SVCT1 transporter saturation. Liposomal vitamin C bypasses this ceiling. A 2016 study in Nutrition and Metabolic Insights found that liposomal vitamin C produced a 1.77-fold higher area-under-curve plasma ascorbate concentration compared to non-liposomal ascorbic acid at equivalent doses (Davis et al. 2016; PMID: 26937191).

Liposomal Glutathione: Reduced glutathione is poorly absorbed from the gut in its intact tripeptide form because brush-border peptidases cleave it into amino acid constituents before transport. Liposomal encapsulation protects the tripeptide from enzymatic degradation. A randomized, double-blind trial demonstrated that 500 mg/day of liposomal glutathione over 4 weeks significantly increased whole-blood glutathione levels compared to placebo, whereas unencapsulated glutathione at the same dose did not produce a significant increase (Richie et al. 2015; PMID: 25522674).

Liposomal Curcumin: Native curcumin has approximately 1% oral bioavailability due to poor aqueous solubility and rapid first-pass glucuronidation. Multiple delivery enhancement strategies exist (phospholipid complexes, nanoparticles, piperine co-administration), with liposomal forms among the highest-performing. Studies using Meriva (a phospholipid-complexed curcumin) showed 29-fold greater plasma curcumin exposure than an equivalent dose of unformulated curcumin extract.

Limitations and Caveats

Liposomal claims are not uniformly validated. The supplement industry uses "liposomal" loosely — some products contain genuine unilamellar vesicles with nanoscale particle sizes (100–400 nm), while others are phospholipid emulsions that provide modest bioavailability enhancement but do not meet the technical definition of a liposome. Particle size, phospholipid purity, and encapsulation efficiency are the critical quality variables, and these are rarely disclosed on consumer labels.

---

Co-Factors and Synergistic Combinations

Bioavailability is not just about the form of a single ingredient — it's about the molecular environment that ingredient encounters. Co-factors are nutrients that are required for the absorption, activation, or function of another nutrient. Formulating without co-factors can leave a high-quality ingredient biologically inert.

Critical Co-Factor Pairings

These co-factor relationships explain why isolated mega-dosing is often less effective than a strategically assembled formula. A 2,000 IU vitamin D capsule taken in isolation on an empty stomach may produce a fraction of the 25(OH)D elevation achievable with the same dose taken alongside K2, magnesium (required for vitamin D receptor activation and the hydroxylation steps that convert D3 to its active form), and a fat-containing meal.

---

How Ones Addresses Bioavailability in Personalized Formulas

Formulation philosophy matters as much as ingredient selection. Ones approaches supplement bioavailability not as an afterthought but as a primary design parameter — every ingredient in the catalog is selected in a form that reflects the current bioavailability evidence.

For omega-3s, Ones sources EPA/DHA in the re-esterified triglyceride form — the form demonstrating approximately 70% superior absorption over ethyl ester concentrates in the Dyerberg et al. crossover trial. For users whose wearable or lab data suggests inflammatory burden or suboptimal lipid profiles, this form distinction translates directly into measurably better outcomes at equivalent capsule doses.

For zinc, Ones uses zinc bisglycinate — the chelated form validated in the Gandia et al. trial to produce 43% higher relative bioavailability than oxide forms. Given that zinc competes with copper and iron at intestinal transporters, the glycinate form's alternate PEPT1 absorption route reduces interference and allows the AI to include therapeutically relevant doses without driving mineral imbalances.

For vitamin D3, Ones always pairs it with MK-7 (vitamin K2 as menaquinone-7 at 90–200 mcg) — the form with the 72-hour half-life and extrahepatic tissue distribution — reflecting the Schurgers et al. evidence on MK-7's superior activation of osteocalcin and MGP relative to K1 or shorter-chain MK-4. Users flagged with suboptimal 25(OH)D on lab results or those in northern latitudes receive D3 doses calibrated to their actual serum levels, not a one-size population average.

For adaptogenic herbs like KSM-66 ashwagandha, Ones uses root extract standardized to ≥5% withanolides — the form used in the clinical trials demonstrating cortisol reduction and stress resilience. The KSM-66 patent covers a water-extraction process that preserves the full-spectrum root alkaloid profile, unlike alcohol-extracted ashwagandha products that may alter the withanolide and withanosides ratio.

The AI practitioner layer that powers Ones formulas applies this form-selection logic across all ~70 ingredients in the catalog, cross-referencing each user's biomarker data, wearable trends, and health goals to build a capsule formula — delivered in a 6 or 9-capsule daily plan — where every ingredient is in a form matched to its bioavailability evidence and dosed within the clinical range used in published trials.

This is the critical difference between grabbing a bottle off a pharmacy shelf and receiving a formula that has been assembled with an understanding of absorption science: not just what you're taking, but which form, at what dose, alongside which co-factors, at what time relative to meals.

---

Practical Absorption Protocols: Getting the Most From Any Formula

Even with optimal ingredient forms, the when and how of supplementation significantly affects bioavailability.

1. Take fat-soluble vitamins (A, D, E, K) and CoQ10 with your largest meal — the one most likely to contain 15–30g of dietary fat. This maximizes micellar solubilization and lymphatic transport.
2. Separate iron and calcium supplements by at least 2 hours — competitive inhibition at shared transporters can reduce iron absorption by up to 60% when taken simultaneously.
3. Take magnesium and B vitamins later in the day — B6 and magnesium have calming, sleep-supportive properties; evening dosing aligns with their functional benefits and avoids the activating effects of morning B-complex stacking for sensitive individuals.
4. Pair vitamin C with any non-heme iron source — 75–250 mg of ascorbic acid taken simultaneously can multiply non-heme iron absorption 3–6 fold by maintaining the Fe²⁺ oxidation state required for DMT1 transport.
5. Avoid high-dose zinc and high-dose iron at the same time — both compete for DMT1; separate by a minimum of 2 hours.
6. Cycle liposomal supplements away from meals high in dietary fat — paradoxically, very high fat intake can slow gastric emptying and reduce the rate of liposomal endocytosis in the proximal small intestine.
7. Maintain consistent timing — many transport proteins are upregulated by circadian rhythm. Vitamin D receptor expression, iron absorption, and several mineral transport genes show diurnal variation, with morning absorption peaks for some nutrients.

---

Comparing Bioavailability-Focused Supplement Approaches

Platforms like Thorne provide practitioner-grade ingredient forms but rely on users to select their own products — a process that requires the same knowledge this article is trying to convey. Ones encodes that knowledge into the AI analysis layer, so users benefit from form optimization without needing a biochemistry background.

---

Key Takeaways

• Bioavailability is the gap between the label dose and what actually reaches your cells — it can range from under 5% (magnesium oxide) to near 90% for optimally delivered liposomal or chelated forms, making form selection the highest-leverage variable in any supplement stack.
• Chelated minerals outperform inorganic salt forms by using alternate peptide transporter pathways (PEPT1) that bypass competitive ion transport, with zinc bisglycinate showing 43% higher relative absorption than oxide in direct crossover studies.
• Liposomal delivery bypasses transporter saturation and first-pass metabolism by mimicking cell membrane fusion — validated for vitamin C, glutathione, and curcumin in controlled trials, though quality varies widely across products claiming the "liposomal" label.
• Co-factors are non-optional — vitamin D3 without K2 and magnesium, non-heme iron without vitamin C, and fat-soluble vitamins without dietary fat are all predictable absorption failures that formulation science can prevent.
• Timing and meal composition affect absorption as meaningfully as form — fat-soluble nutrients taken with high-fat meals can increase serum levels 50%+; mineral competitors taken simultaneously can reduce absorption by comparable margins.
• Personalized platforms like Ones address bioavailability at the system level — selecting clinically validated forms, pairing co-factors, calibrating doses to actual lab values, and providing timing guidance that generic supplements and even practitioner-grade products typically leave to the user to figure out alone.